114 related articles for article (PubMed ID: 17543949)
1. Prostate cancer and race.
Brawley OW; Jani AB; Master V
Curr Probl Cancer; 2007; 31(3):211-25. PubMed ID: 17543949
[No Abstract] [Full Text] [Related]
2. Screening for prostate cancer.
Brawley OW; Ankerst DP; Thompson IM
CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
[TBL] [Abstract][Full Text] [Related]
3. Link between exercise and lower risk for prostate cancer found.
AVMA Group Health and Life Insurance Trust
J Am Vet Med Assoc; 2005 Sep; 227(6):858-9. PubMed ID: 16190576
[No Abstract] [Full Text] [Related]
4. New trial data do not end the PSA screening debate.
Vastag B
J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
[No Abstract] [Full Text] [Related]
5. Access to prostate cancer care and implications for survival among minorities.
Oliver MN
J Urol; 2009 Feb; 181(2):447-8. PubMed ID: 19095248
[No Abstract] [Full Text] [Related]
6. The little gland that could.
Voelker R
Bus Health; 2000; 18(10 Suppl A):7-9. PubMed ID: 11146854
[No Abstract] [Full Text] [Related]
7. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer.
Dean M; Downey P
Prof Nurse; 1997 Jul; 12(10):722-4. PubMed ID: 9248453
[No Abstract] [Full Text] [Related]
9. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
10. Prostate-cancer screening in an Afro-Caribbean population: the Tobago Prostate Cancer Screening Study.
Patrick A
BJU Int; 2010 Mar; 105(6):745-6. PubMed ID: 20353535
[No Abstract] [Full Text] [Related]
11. Prostate cancer screening--finding the middle road forward.
Lamb DS; Delahunt B
N Z Med J; 2005 Feb; 118(1209):U1306. PubMed ID: 15711635
[No Abstract] [Full Text] [Related]
12. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
D'Amico AV; Chen MH
J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
[No Abstract] [Full Text] [Related]
13. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
14. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
Takechi H; Ito K; Yamamoto T; Miyakubo M; Ohi M; Suzuki K
Urology; 2008 Nov; 72(5):1111-5. PubMed ID: 18342926
[TBL] [Abstract][Full Text] [Related]
16. Explaining the race difference in prostate cancer stage at diagnosis.
Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening.
Witte MN; Morton RA
Am Fam Physician; 1998 Aug; 58(2):342, 345-6, 348. PubMed ID: 9713390
[No Abstract] [Full Text] [Related]
18. Short- and long-term mortality with localized prostate cancer.
Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
[TBL] [Abstract][Full Text] [Related]
19. Effect of BMI on primary treatment of prostate cancer.
Davies BJ; Walsh TJ; Ross PL; Knight SJ; Sadetsky N; Carroll PR; Kane CJ
Urology; 2008 Aug; 72(2):406-11. PubMed ID: 18267336
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
